Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

BCL2L1 Antikörper

Dieses Anti-BCL2L1-Antikörper ist ein Maus Monoklonal-Antikörper zur Detektion von BCL2L1 in FACS. Geeignet für Human. Dieses Primary Antibody wurde in 1 Publikation zitiert.
Produktnummer ABIN135021

Kurzübersicht für BCL2L1 Antikörper (ABIN135021)

Target

Alle BCL2L1 Antikörper anzeigen
BCL2L1 (BCL2-Like 1 (BCL2L1))

Reaktivität

  • 236
  • 136
  • 120
  • 51
  • 25
  • 12
  • 10
  • 10
  • 5
  • 5
  • 4
  • 2
  • 2
  • 1
Human

Wirt

  • 170
  • 95
  • 1
Maus

Klonalität

  • 152
  • 114
Monoklonal

Konjugat

  • 138
  • 27
  • 11
  • 5
  • 5
  • 4
  • 4
  • 4
  • 4
  • 4
  • 4
  • 4
  • 4
  • 4
  • 4
  • 4
  • 4
  • 4
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Dieser BCL2L1 Antikörper ist unkonjugiert

Applikation

  • 181
  • 100
  • 64
  • 61
  • 57
  • 44
  • 32
  • 28
  • 28
  • 27
  • 21
  • 14
  • 10
  • 7
  • 6
  • 4
  • 3
  • 3
  • 2
  • 2
Flow Cytometry (FACS)

Klon

7B2-5
  • Spezifität

    Human/Mouse/Rat/Rhesus Bcl-xL

    Produktmerkmale

    Mouse Anti-Bcl-xL-UNLB

    Aufreinigung

    Purified

    Immunogen

    Recombinant human Bcl-xS

    Isotyp

    IgG3
  • Applikationshinweise

    • Applications: FC - Quality tested , IHC-PS - Reported in literature , ICC - Reported in literature , WB - Reported in literature , IP - Reported in literature , ELISA - Reported in literature
    • Working Dilutions: Flow Cytometry FITC and BIOT conjugates 3 g/106 cells PE conjugate 0.3 g/106 cells For flow cytometry, the suggested use of these reagents is in a final volume of 100 L Immunoblotting Purified (UNLB) antibody 1 g/mL

    Probenmenge

    1 mL

    Beschränkungen

    Nur für Forschungszwecke einsetzbar
  • Konzentration

    0.1 mg/mL

    Buffer

    0.1 mg of purified immunoglobulin in 1.0 mL of borate buffered saline,  pH 8.2. No preservatives or amine-containing buffer salts added

    Konservierungsmittel

    Without preservative

    Handhabung

    Each reagent is stable for the period shown on the bottle label if stored as directed.

    Lagerung

    4 °C

    Informationen zur Lagerung

    Store at 2-8°C
  • Gottschalk, Boise, Oltvai, Accavitti, Korsmeyer, Quintáns, Thompson: "The ability of Bcl-x(L) and Bcl-2 to prevent apoptosis can be differentially regulated." in: Cell death and differentiation, Vol. 3, Issue 1, pp. 113-8, (2006) (PubMed).

  • Target

    BCL2L1 (BCL2-Like 1 (BCL2L1))

    Andere Bezeichnung

    Bcl-xL

    Hintergrund

    Apoptosis, or programmed cell death, is a well-documented phenomenon in many cellular systems. It plays a key role in tissue and organ development as well as in adult tissues during cell turnover. Apoptosis can be induced by a variety of internal and external stimuli including growth factor deprivation, cytokine treatment, antigen-receptor engagement, cell-cell interactions, irradiation and glucocorticoid treatment. Bcl-2 and one of its homologues, Bcl-xL, protect cells from apoptosis, while other homologues of Bcl-2 such as Bax, Bad and Bak have been shown to enhance apoptosis. Bcl-xL has been shown to block apoptosis which is induced by a variety of stimuli and, under certain conditions, offers greater protection against apoptosis than Bcl-2. In contrast, Bad and Bax inhibit the protective functions of Bcl-xL and Bcl-2, respectively. Although heterodimerization between Bcl-xL/Bad and Bcl-2/Bax was originally thought to be essential for the differential anti-apoptotic activity of Bcl-xL and Bcl-2, other results suggest that the formation of heterodimers may not be necessary for this death-repressing activity.

    Pathways

    Apoptose, Negative Regulation of intrinsic apoptotic Signaling
Sie sind hier:
Chat with us!